![Nathalie Cartier-Lacave](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Nathalie Cartier-Lacave is the founder of BrainVectis SAS, where she holds the title of Chief Scientist Officer since 2015.
Aktive Positionen von Nathalie Cartier-Lacave
Unternehmen | Position | Beginn |
---|---|---|
BrainVectis SAS
![]() BrainVectis SAS BiotechnologyHealth Technology BrainVectis SAS provides gene therapy services. It develops gene therapy treatments for neurodegenerative diseases by targeting the cholesterol pathway in the brain to restore cholesterol metabolism. The company was founded by Nathalie Cartier-Lacave and Jérôme Becquart in 2015 and is headquartered in Paris, France. | Gründer | 01.01.2015 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
BrainVectis SAS
![]() BrainVectis SAS BiotechnologyHealth Technology BrainVectis SAS provides gene therapy services. It develops gene therapy treatments for neurodegenerative diseases by targeting the cholesterol pathway in the brain to restore cholesterol metabolism. The company was founded by Nathalie Cartier-Lacave and Jérôme Becquart in 2015 and is headquartered in Paris, France. | Health Technology |